#IDXX hashtag - Bluesky

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus IDEXX (NASDAQ: IDXX) launched the ImageVue DR50 Plus digital imaging system on January 15, 2026, a connected veterinary radiography solution offering AI-powered imaging and integrated workflows. The system claims up to 25% lower radiation versus IDEXX’s prior DR50 and up to 60% lower radiation versus other veterinary systems, plus a new 17" x 17" panel option. Features include automated image optimization, irradiated side sampling to reduce retakes, IDEXX Web PACS integration, AI hanging protocols and vertebral heart scores, direct Telemedicine submission to 160+ board-certified specialists, and a claimed >45% reduction in clicks to submit cases. Available in the United States and Canada.

2 months ago

#IDXX Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

www.stocktitan.net/news/IDXX/lowest-dose-ra...

0 0 0 0

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results IDEXX Laboratories (NASDAQ: IDXX) will release its 2025 fourth quarter and full year financial results on Monday, February 2, 2026 before market open. An analyst conference call will begin at 8:30 a.m. ET that day and will be available via a live webcast, telephone, and an archived webcast posted after 1:00 p.m. ET that will remain available for one year.Investors can access the live webcast, a transcript of prepared remarks, and a Q4 2025 Earnings Snapshot from the company investor site at www.idexx.com/investors. To join the live call by phone dial 1-800-330-6730 or 1-213-279-1575 and reference passcode 263206.

2 months ago

#IDXX IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

www.stocktitan.net/news/IDXX/idexx-laborato...

0 0 0 0

Stock index futures edge higher as investors assess U.S. move in Venezuela Stock market futures rise as investors weigh U.S. action in Venezuela, oil supply risks, and falling Treasury yields.

3 months ago

Stock index futures edge higher as investors assess U.S. move in Venezuela

#spx #indu #us100:ind #hca #ctas #idxx #efx #txt #payc #us10y #us2y

Origin | Interest | Match

0 0 0 0

spacex

@spacex.activitypub.awakari.com.ap.brid.gy

4 months ago

Ron Baron Says Tesla Could 5X And SpaceX 10X — Says Musk Is 'Like Da Vinci' - Tesla (NASDAQ:TSLA) Billionaire investor Ron Baron is up big on his investments in Tesla and SpaceX and he doesn't plan on selling.

Ron Baron Says Tesla Could 5X And SpaceX 10X — Says Musk Is 'Like Da Vinci' Billionaire investor Ron Baron is up big on his investments in Tesla and SpaceX and he doesn't plan on sell...

#ACGL #Baron #Capital #CSGP #Elon #Musk #Expert #Ideas #GWRE #H #IDXX

Origin | Interest | Match

1 0 0 0

5 months ago

#IDXX #b34f1081-21e6-4e54-aacb-36515146c344 #earningscall-transcripts

Origin | Interest | Match

0 0 0 0

IDEXX Laboratories Announces Third Quarter Results Third quarter EPS included $0.17 per share in tax benefits from share-based compensation, $0.09 per share of increased tax expense related to impacts of recent U.S. tax law changes, and $0.02 per share benefit from currency changes. CAG revenue growth was led by CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic, including 18% reported...

5 months ago

#IDXX IDEXX Laboratories Announces Third Quarter Results

www.stocktitan.net/news/IDXX/idexx-laborato...

0 0 0 0

7 months ago

#INTC #^IXIC #IDXX #APP #1ecdea1d-6f57-4777-bf4c-24820bebfe5b #investing

Origin | Interest | Match

0 0 0 0

Idexx (IDXX) Q2 Revenue Jumps 11% | The Motley Fool

8 months ago

#IDXX #b79b3730-0202-47e7-aa2b-b24a254b9ab9 #data-news

Origin | Interest | Match

0 0 0 0

IDEXX Laboratories Announces Second Quarter Results IDEXX Laboratories (NASDAQ: IDXX) reported strong Q2 2025 results with 11% revenue growth to $1,109 million and EPS of $3.63, up 49% as reported. The company's performance was driven by 9% organic growth in Companion Animal Group (CAG) Diagnostics recurring revenue and record quarterly instrument placements, including nearly 2,400 IDEXX inVue Dx™ units.IDEXX increased its 2025 revenue guidance to $4,205-$4,280 million, reflecting a $90 million increase at midpoint. The company also raised its EPS outlook to $12.40-$12.76, a $0.40 increase from previous guidance, supported by improved revenue outlook, operating margin expansion, and favorable tax rates.

8 months ago

#IDXX IDEXX Laboratories Announces Second Quarter Results

www.stocktitan.net/news/IDXX/idexx-laborato...

0 0 0 0

Turing

@newslettertrader.com

8 months ago

The newsletters were in full bloom this week — the portfolio climbed 1.40%, led by a standout surge from Newsletter 9 (+9.83%). Newsletter 2 and 5 also found their rhythm, each gaining over 5%. Even Newsletter 3, the heavyweight, added more fuel with a solid +3.44%. 🌴🐸🌲

#IDXX #SSRM #AU

0 0 0 0

Turing

@newslettertrader.com

8 months ago

A red tide washed across the portfolio today. Newsletter 10 took the brunt with a sharp -5.92% drop, while the rest held up better, though still in the red. Newsletter 7 softened the blow with only a -0.21% dip. 👺🍓🚨

#IDXX #HWM #PLTR

0 0 0 0

IDEXX Unveils Game-Changing Dog Disease Test: Breakthrough for Detecting Life-Threatening Addison's Disease New point-of-care test enables instant diagnosis of critical canine endocrine disorders. Rolling out to 75,000+ veterinary practices globally. See breakthrough features.

9 months ago

#IDXX Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

www.stocktitan.net/news/IDXX/third-expansio...

0 0 0 0

Subversive Capital

@subversivecapital.bsky.social

10 months ago

IDXX just popped up in another Congressional portfolio. Rep. Jefferson Shreve disclosed this morning that he bought IDEXX Labs on April 6 — days before the biotech bill dropped📈

He also reported a flurry of other trades. Tracked in #GOP ETF.

#IDXX #ETFs #TradeLikeCongress #Congress

1 2 0 0

Subversive Capital

@subversivecapital.bsky.social

10 months ago

🚨 Follow-up on Rep. April McClain Delaney’s IDXX trades:

She bought shares on April 9 — the same day Congress introduced a biotech funding bill that sent the stock up 10%.

That bill? Referred to the two committees she sits on.

Since then, #IDXX is up 30%.

#CongressTrading #NANC #Biotech #ETFs

0 0 0 0

Subversive Capital

@subversivecapital.bsky.social

10 months ago

🧵1/2 Rep. April McClain Delaney just filed new stock trades.

Among them:
🔬 Bio-Techne #TECH — biotech
🐾 IDEXX Labs #IDXX — veterinary diagnostics
🛠️ Core & Main #CNM — infrastructure

#CongressTrading #Biotech #Agriculture #ETFs #Congress

0 0 1 0

IDEXX Earnings Reveal Massive $1.5B Buyback Plan as Pet Health Leader Expands Cancer Testing IDEXX reports strong Q4 with 6% revenue growth, announces game-changing cancer diagnostics launch and ambitious $1.5B share repurchase program for 2025. EPS soars 13% to $2.62.

1 year ago

#IDXX IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

www.stocktitan.net/news/IDXX/idexx-laborato...

0 0 0 0

IDEXX Launches Breakthrough $15 Blood Test for Early Dog Cancer Detection: Cancer Dx Coming 2025 IDEXX unveils Cancer Dx™, a revolutionary $15 blood test for early lymphoma detection in dogs. The affordable screening targets 20M at-risk dogs in North America, launching March 2025.

1 year ago

#IDXX IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma

www.stocktitan.net/news/IDXX/idexx-announce...

0 0 0 0

IDEXX Laboratories Sets Q4 and Full Year 2024 Earnings Release Date for February 3 Global pet healthcare leader IDEXX Laboratories will announce Q4 and full-year 2024 financial results on February 3, 2025, with an analyst conference call at 8:30 AM ET.

1 year ago

#IDXX IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

www.stocktitan.net/news/IDXX/idexx-laborato...

0 0 0 0